Skip to search formSkip to main contentSkip to account menu

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Known as: HIV-1 NNRTI, HIV-1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, HIV-1 Nonnucleoside Analog Reverse Transcriptase Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Different adjuvants and delivery systems have been used to enhance the potency of DNA vaccines against viral diseases… 
2011
2011
c/mL/day, P< 0.01) • Phase 1 decay more prolonged for RAL + LPV/r (18 vs 13 days; P< 0.01) • Phase 2 decay similar between… 
2001
2001
Summary: A retrospective study was set up to investigate the frequency of zidovudine (ZDV)‐resistant HIV‐1 in infected newborns… 
Review
2000
Review
2000
The confounding problem in treatment of breast cancer is the metastasis of breast tumour. Reverse transcriptase polymerase chain… 
1991
1991
To express HIV-1 reverse transcriptase in E. coli a number of genetic constructions containing reverse transcriptase and virus… 
Review
1982
Review
1982
Chromatography on heparin-Sepharose, known for its affinity for nucleotide-binding polypeptides, was used to purify the viral RNA… 
1981
1981
Two DNA polymerases with properties of viral RNA-directed DNA polymerase were found in the placenta of a patient with breast… 
1974
1974
Evidence is presented that DNA polymerase of avian myeloblastosis virus has an obligatory zinc requirement for activity. Previous… 
1972
1972
Virions from hamster cells transformed by a new strain of murine sarcoma virus (MSV) appear to represent a form of MSV deficient… 
1972
1972
Incubation of rat cells transformed by Rous sarcoma virus (RSV) in an arginine-deficient medium resulted in accumulation of…